Arch Capital Group (ACGL) Receiving Favorable Press Coverage, Study Shows

Media stories about Arch Capital Group (NASDAQ:ACGL) have been trending positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Arch Capital Group earned a news sentiment score of 0.35 on Accern’s scale. Accern also assigned news stories about the insurance provider an impact score of 46.0523593010355 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Here are some of the news stories that may have effected Accern Sentiment’s analysis:

How to Become a New Pot Stock Millionaire

Shares of ACGL traded down $0.99 during mid-day trading on Friday, hitting $85.41. The stock had a trading volume of 371,394 shares, compared to its average volume of 883,457. The firm has a market cap of $11,811.12, a PE ratio of 26.61, a PEG ratio of 1.26 and a beta of 0.61. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.79 and a quick ratio of 0.79. Arch Capital Group has a 52 week low of $83.16 and a 52 week high of $102.60.

Arch Capital Group (NASDAQ:ACGL) last issued its earnings results on Monday, February 12th. The insurance provider reported $1.34 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.13 by $0.21. The firm had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.09 billion. Arch Capital Group had a return on equity of 5.87% and a net margin of 11.21%. The business’s revenue was up 27.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.13 earnings per share. sell-side analysts anticipate that Arch Capital Group will post 6.23 earnings per share for the current fiscal year.

A number of analysts recently commented on the company. Wells Fargo set a $100.00 price target on Arch Capital Group and gave the stock a “hold” rating in a report on Sunday, December 10th. BidaskClub upgraded Arch Capital Group from a “strong sell” rating to a “sell” rating in a report on Tuesday, January 16th. ValuEngine lowered Arch Capital Group from a “hold” rating to a “sell” rating in a report on Thursday, March 1st. Finally, Keefe, Bruyette & Woods upgraded Arch Capital Group from a “market perform” rating to an “outperform” rating in a report on Thursday, March 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the stock. Arch Capital Group has an average rating of “Hold” and a consensus target price of $102.43.

In other Arch Capital Group news, CFO Mark Donald Lyons sold 6,000 shares of the business’s stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $84.16, for a total value of $504,960.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Constantine Iordanou bought 7,000 shares of the stock in a transaction on Thursday, February 15th. The stock was purchased at an average price of $23.80 per share, for a total transaction of $166,600.00. Following the completion of the purchase, the chief executive officer now owns 7,000 shares of the company’s stock, valued at $166,600. The disclosure for this purchase can be found here. Insiders own 6.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Arch Capital Group (ACGL) Receiving Favorable Press Coverage, Study Shows” was posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another domain, it was illegally stolen and republished in violation of US & international copyright & trademark laws. The legal version of this story can be read at https://www.tickerreport.com/banking-finance/3339366/arch-capital-group-acgl-receiving-favorable-press-coverage-study-shows.html.

Arch Capital Group Company Profile

Arch Capital Group Ltd., together with its subsidiaries, provides property, casualty, and mortgage insurance and reinsurance products worldwide. The company's Insurance segment offers primary and excess casualty coverages; loss sensitive primary casualty insurance programs; collateral protection, debt cancellation, and service contract reimbursement products; directors' and officers' liability, errors and omissions liability, employment practices and fiduciary liability, crime, professional indemnity, and other financial related coverages; medical professional and general liability insurance coverages; and workers' compensation and umbrella liability, as well as commercial automobile and inland marine products.

Insider Buying and Selling by Quarter for Arch Capital Group (NASDAQ:ACGL)

Receive News & Ratings for Arch Capital Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arch Capital Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Esperion Therapeutics  PT Raised to $121.00 at Northland Securities
Esperion Therapeutics PT Raised to $121.00 at Northland Securities
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources  Stock
Darrel S. Purdy Sells 3,500 Shares of Paramount Resources Stock
Antibe Therapeutics Inc  Director Sells C$74,750.40 in Stock
Antibe Therapeutics Inc Director Sells C$74,750.40 in Stock
Unit  Earning Somewhat Positive Press Coverage, Study Shows
Unit Earning Somewhat Positive Press Coverage, Study Shows
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc.  Stock
Oleg M. Pohotsky Buys 10,000 Shares of New America High Income Fund Inc. Stock
Revance Therapeutics  Given News Impact Score of 0.22
Revance Therapeutics Given News Impact Score of 0.22


Leave a Reply

© 2006-2018 Ticker Report. Google+.